CardioComm Solutions Inc (EKG) - Product Pipeline Analysis, 2019 Update

Region:North America

Author(s):

Product Code:GDME6342PD

Download Sample Report download
Buy the Full ReportStarting from $750
Published on

October 2019

Total pages

29

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $750

About the Report

About the Report

Summary

CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. It offers software engineering of computer based electrocardiogram management and reporting software. Its products include software, hardware, software modules and other products. CardioComm provides ECG management services and enterprise solutions. The company also offers PC and LAN based products, internet based SAAS and ASP software, a medical ECG service, arrhythmia monitoring ECG protocols and supports traditional transtelephonic transmissions through wireless communication. The company caters to medical diagnostic and consumer market industries. It markets its products in Canada and the US. CardioComm is headquartered in North York, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company CardioComm Solutions Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Products

Products

CardioComm Solutions Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Nightingale Informatix Corp

Covalon Technologies Ltd

Table of Contents

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

CardioComm Solutions Inc Company Overview

CardioComm Solutions Inc Company Snapshot

CardioComm Solutions Inc Pipeline Products and Ongoing Clinical Trials Overview

CardioComm Solutions Inc-Pipeline Analysis Overview

CardioComm Solutions Inc-Key Facts

CardioComm Solutions Inc-Major Products and Services

CardioComm Solutions Inc Pipeline Products by Development Stage

CardioComm Solutions Inc Pipeline Products Overview

GEMS Rhythm

GEMS Rhythm Product Overview

GEMS Rhythm AF

GEMS Rhythm AF Product Overview

GEMS Rhythm QT

GEMS Rhythm QT Product Overview

HeartCheck Beat

HeartCheck Beat Product Overview

HeartCheck ECG Sport-Three-Part Version

HeartCheck ECG Sport-Three-Part Version Product Overview

HeartCheck ECG Sport-Two-Part Version

HeartCheck ECG Sport-Two-Part Version Product Overview

CardioComm Solutions Inc-Key Competitors

CardioComm Solutions Inc-Key Employees

CardioComm Solutions Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

CardioComm Solutions Inc, Recent Developments

May 14, 2019: Cardiocomm Solutions GEMS Universal ECG app launched in partnership with multiple ECG device manufacturers

May 09, 2019: Cardiocomm solutions HeartCheck Cardibeat handheld ECG device cleared by Health Canada for direct-to-consumer sales

Apr 12, 2019: Cardiocomm Solutions provides financing update

Apr 09, 2019: Cardiocomm Solutions files with Health Canada for direct to consumer sales approval of the Heartcheck Cardibeat Handheld ECG Device

Mar 25, 2019: Cardiocomm Solutions launches new GEMS Mobile Universal ECG app expanding ECG reporting services across global markets

Mar 21, 2019: Cardiocomm Solutions leverages the Gems Mobile ECG app to bring a third FDA cleared Heartcheck Branded ECG device to the us consumer markets

Mar 14, 2019: Cardiocomm Solutions releases remote 12-Lead ECG Telemed with arrythmia detection and ECG reading services

Mar 05, 2019: CardioComm Solutions prepares new FDA Applications for Direct-to-consumer and physician use Cardiac Arrhythmia Algorhythms

Feb 25, 2019: Innovation continues as the FDA clears cardiocomm solutions' novel ECG smartphone app and HEARTCHECK device for direct to consumer sales

Dec 31, 2018: Cardiocomm solutions' Heartcheck Cardibeat FDA 510(k)review extended

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List of Figure

List of Figures

CardioComm Solutions Inc Pipeline Products by Equipment Type

CardioComm Solutions Inc Pipeline Products by Development Stage


List of Table

List of Tables

CardioComm Solutions Inc Pipeline Products and Ongoing Clinical Trials Overview

CardioComm Solutions Inc Pipeline Products by Equipment Type

CardioComm Solutions Inc Pipeline Products by Indication

CardioComm Solutions Inc, Key Facts

CardioComm Solutions Inc, Major Products and Services

CardioComm Solutions Inc Number of Pipeline Products by Development Stage

CardioComm Solutions Inc Pipeline Products Summary by Development Stage

GEMS Rhythm-Product Status

GEMS Rhythm-Product Description

GEMS Rhythm AF-Product Status

GEMS Rhythm AF-Product Description

GEMS Rhythm QT-Product Status

GEMS Rhythm QT-Product Description

HeartCheck Beat-Product Status

HeartCheck Beat-Product Description

HeartCheck ECG Sport-Three-Part Version-Product Status

HeartCheck ECG Sport-Three-Part Version-Product Description

HeartCheck ECG Sport-Two-Part Version-Product Status

HeartCheck ECG Sport-Two-Part Version-Product Description

CardioComm Solutions Inc, Key Employees

CardioComm Solutions Inc, Other Locations

CardioComm Solutions Inc, Subsidiaries

Glossary

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022